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Abstract
Background: Policy has a tremendous potential to improve population health when informed by research evidence.
Such evidence, however, typically plays a suboptimal role in policymaking processes. The field of policy dissemination and
implementation research (policy D&I) exists to address this challenge. The purpose of this study was to: (1) determine the
extent to which policy D&I was funded by the National Institutes of Health (NIH), (2) identify trends in NIH-funded policy
D&I, and (3) describe characteristics of NIH-funded policy D&I projects.
Methods: The NIH Research Portfolio Online Reporting Tool was used to identify all projects funded through D&I-focused
funding announcements. We screened for policy D&I projects by searching project title, abstract, and term fields for
mentions of “policy,” “policies,” “law,” “legal,” “legislation,” “ordinance,” “statute,” “regulation,” “regulatory,” “code,” or “rule.”
A project was classified as policy D&I if it explicitly proposed to conduct research about the content of a policy, the
process through which it was developed, or outcomes it produced. A coding guide was iteratively developed, and all
projects were independently coded by two researchers. ClinicalTrials.gov and PubMed were used to obtain additional
project information and validate coding decisions. Descriptive statistics—stratified by funding mechanism, Institute, and
project characteristics—were produced.
Results: Between 2007 and 2014, 146 projects were funded through the D&I funding announcements, 12 (8.2 %) of
which were policy D&I. Policy D&I funding totaled $16,177,250, equivalent to 10.5 % of all funding through the D&I
funding announcements. The proportion of funding for policy D&I projects ranged from 14.6 % in 2007 to 8.0 % in
2012. Policy D&I projects were primarily focused on policy outcomes (66.7 %), implementation (41.7 %), state-level
policies (41.7 %), and policies within the USA (83.3 %). Tobacco (33.3 %) and cancer (25.0 %) control were the primary
topics of focus. Many projects combined survey (58.3 %) and interview (33.3 %) methods with analysis of archival data
sources.
Conclusions: NIH has made an initial investment in policy D&I research, but the level of support has varied between
Institutes. Policy D&I researchers have utilized a variety of designs, methods, and data sources to investigate the
development processes, content, and outcomes of public and private policies.

Background
Policy has a tremendous potential to improve population
health [1, 2]. The extent to which policy produces such
outcomes, however, often depends upon the degree to
which it is informed by scientific knowledge and aligned
with evidence-based interventions [3–5]. Unfortunately,
research typically plays a minor role in policymaking
* Correspondence: jpp46@drexel.edu
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processes [6, 7]. For decades, scholars have documented
myriad barriers to translating research into policy—including political influences, economic constraints, scientific uncertainty, and institutional culture [8–20].
The field of health policy dissemination and implementation research (policy D&I) exists to address these
challenges. Policy D&I is focused on generating knowledge to effectively spread research evidence among policymakers and integrate evidence-based interventions
into policy designs [5]. Policy D&I, known as policy
“knowledge translation and exchange” outside of the
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USA, has evolved over the past 40 years. The 1970s and
1980s were marked by interest in how social science research was used in public policymaking and saw the development of key contributions to the field—such as
Weiss’ typology of research evidence [7] and Caplan’s
two communities theory of knowledge utilization [17].
In the 1990s and 2000s, frameworks and instruments for
policy D&I emerged [21–25] and the field was embraced
within the discipline of public health [9, 26, 27]. Today,
policy D&I is a priority of the World Health Organization
[28, 29] and a major focus of journals such as Health Research Policy and Systems and Evidence & Policy.
The history of policy D&I has demonstrated that government funding is essential for a county to develop and
maintain a robust policy D&I research infrastructure
[22, 30]. Outside of the USA, governments have made
sustained investments in policy D&I research and initiatives to promote the use of research evidence in health
policymaking. Examples include the Canadian Institutes
of Health Research’s integrated knowledge translation
programs, the National Health and Medical Research
Council of Australia’s Partnership Projects and Centres,
and the UK National Institute for Health Research’s Collaboration for Leadership in Applied Health Research
and Care. While national governments have invested in
policy D&I abroad, policy D&I research has largely
existed outside of the mainstream, government-funded
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health research enterprise in the USA [6]. This is potentially changing, however, as the National Institutes of
Health (NIH)—the largest government funder of health
research in the USA—has recently invested in the
broader field of D&I research and identified policy D&I
as a priority [31].
In 2002, the National Institute of Mental Health issued
a Program Announcement (PAR) entitled “Dissemination and Implementation Research in Mental Health”
that highlighted the importance of developing effective
strategies to disseminate research findings to the policymakers [32]. In 2005, the PAR was re-issued under the
broader name “Dissemination and Implementation
Research in Health” (D&IRH) with more participating
Institutes (e.g., the National Cancer Institute, National
Institute on Drug Abuse) [33]. In 2007, the NIH Center
for Scientific Review created a permanent D&IRH study
section to evaluate D&I proposals, re-affirming NIH’s investment in the field [34]. In 2013, the “D&IRH” PAR
was re-issued, this time with a greater emphasis on policy D&I research [35]. For example, the PAR encouraged
applications that “address[ed] the complexity of bridging
research, policy and practice.”
NIH has expressed interest in policy D&I research, but
the extent to which it has funded research in this area is
unclear. Two recent studies reviewed NIH D&I funding
related to specific topics; one study focused on nursing

Fig. 1 Flow diagram summarizing the process used to identify policy D&I research projects funded by NIH, federal fiscal years 2007–2014. NIH
National Institutes of Health, D&I dissemination and implementation, FOAs funding opportunity announcements
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Table 1 NIH-funded policy D&I research projects by funding mechanism, Institute, and percentage of all research funded through
D&I FOAs, federal fiscal years 2007–2014
Funding
source

Number of projects funded through Amount funded through D&I
D&I FOAs
FOAs (%)a

Number of policy D&I projects
funded (%)b

Amount funded for policy of
D&I (%)b

146

$154,339,271 (0.09)

12 (8.2)

$16,177,250 (10.5)

Total

Funding mechanism
R01

82

$134,439,725 (0.19)

7 (8.5)

$14,626,930 (10.9)

R03

12

$1,745,967 (0.25)

1 (8.3)

$150,000 (8.6)

R21

51

$18,042,301 (0.36)

4 (7.8)

$1,400,320 (7.8)

R34

1

$111,278 (0.03)

0 (0)

$0 (0)

NCI

46

$47,631,105 (0.19)

6 (13.0)

$5,993,592 (12.6)

NIMH

40

$51,237,349 (0.57)

3 (7.5)

$4,328,310 (8.4)

NIAID

18

$13,093,827 (0.06)

1 (5.6)

$320,720 (2.4)

NIDA

12

$11,691,400 (0.19)

1 (8.3)

$1,872,963 (16.0)

NHLBI

8

$12,248,387 (0.07)

1 (12.5)

$3,393,577 (27.7)

NINR

7

$8,983,908 (1.03)

0 (0)

$0 (0)

FIC

4

$667,849 (0.29)

0 (0)

$0 (0)

OD

3

$384,426 (0.02)

1 (33.3)

$268,088 (69.7)

Institute

NIDCR

3

$2,538,584 (0.11)

0 (0)

$0 (0)

NCCAM

2

$864,887 (0.17)

0 (0)

$0 (0)

NIDCD

2

$352,052 (0.01)

0 (0)

$0 (0)

NINDS

1

$2,601,603 (0.02)

0 (0)

$0 (0)

NIDDK

1

$1,396,497 (0.01)

0 (0)

$0 (0)

NIAAA

1

$408,039 (0.02)

0 (0)

$0 (0)

NIA

1

$239,358 (0.00)

0 (0)

$0 (0)

NIH National Institutes of Health, NCI National Cancer Institute, NIMH National Institute of Mental Health, NIDA National Institute on Drug Abuse, NHLBI National
Heart, Lung, and Blood Institute, OD NIH Office of the Director, NIAID National Institute of Allergy and Infectious Diseases, NINR National Institute of Nursing
Research, FIC Fogarty International Center, NIDCR National Institute of Dental and Craniofacial Research, NCCAM National Center for Complementary and
Alternative Medicine, NIDCD National Institute on Deafness and Other Communication Disorders, NINDS National Institute of Neurological Disorders and Stroke,
NIDDK National Institute of Diabetes and Digestive and Kidney Diseases, NIAAA National Institute on Alcohol Abuse and Alcoholism, NIA National Institute on
Aging, D&I dissemination and implementation, FOAs funding opportunity announcements
a
Percentages indicating the proportion of D&I funding within total NIH research grant spending category (e.g., proportion of research grant funding for R01
projects that were for D&I projects, $134,439,725/$71,808,892,375 = 0.19 %). Total research grant amounts for each NIH spending category are not shown.
Source: https://report.nih.gov/fundingfacts/fundingfacts.aspx
b
Percentages indicating the proportion of policy D&I within total D&I category (e.g., proportion of R01 projects funded through D&I FOAs that were policy D&I
projects, 7/82 = 8.5 %)

[36] and the other focused on cancer control [37]. A
similar review of policy D&I research is needed to assess
growth of the field and identify funding gaps. Such a
study would support growth in the field of policy D&I in
the USA by providing investigators with a menu of approaches to policy D&I research that can be adopted
and adapted when developing proposals. This article reports the results of a study that was conducted to address these knowledge gaps. The aims of the study were
to: (1) determine the extent to which policy D&I research has been funded by NIH between 2007 and 2014,
(2) identify trends in NIH-funded policy D&I research,
and (3) describe the characteristics of NIH-funded policy
D&I research projects.

Methods
We used the NIH Research Portfolio Online Reporting
Tool [38] to identify all projects that received funding
during any US fiscal year between 2007 and 2014
through the D&I funding opportunity announcements
(FOAs) Dissemination and Implementation Research in
Health (PARs: 06-039, 06-071, 06-072, 06-520, 06-521,
07-086, 10-038, 10-039, 10-040, 13-054, 13-055, 13-056)
or Dissemination and Implementation Research in
Mental Health (PA 02-131). We selected 2007 as the
starting point because it was the first year that projects
supported by the Dissemination and Implementation
Research in Health FOAs received funding. For each
project, we extracted the title, abstract, project terms,
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Fig. 2 Annual trends in NIH funding for D&I research, federal fiscal years 2007–2014. “Policy D&I funding” and “all D&I FOA funding” in millions, “all NIH
research grant funding” in billions, US dollars. NIH National Institutes of Health, D&I dissemination and implementation, FOAs funding
opportunity announcements

award amount per fiscal year, funding mechanism, and
Institute.
Our review was guided by Bogenschneider’s definition
of policy as: “the development, enactment, and implementation of a plan or course of action carried out
through law, rule, code, or other mechanism in the public or private sector” [5]. Accordingly, we identified potential policy D&I projects by searching the project title,
abstract, and term fields for mentions of “policy,” “policies,” “law,” “legal,” “legislation,” “ordinance,” “statute,”
“regulation,” “regulatory,” “code,” or “rule.” Two coders
then independently reviewed project abstracts and developed preliminary coding categories to capture project
characteristics. These categories reflected themes in that
data, categories used in previous NIH D&I funding reviews [36, 37], and policy D&I scholarship [3–6, 8, 9].
The coders then jointly developed a coding guide and independently re-reviewed and coded the projects. Because
many projects were not exclusively focused on policy D&I,
projects were coded according to their policy D&I features. Incongruent coding decisions were identified in
<10 % of projects and resolved through discussions.
We classified a project as policy D&I if it explicitly
proposed to conduct empirical research about the “content” of a policy (e.g., analysis of the text of clean indoor
air laws), the “process” through which it was developed
(e.g., assessment of how state legislators use research
evidence when developing clean indoor air laws), or the
“outcomes” it produced (e.g., evaluation of the impacts
of clean indoor air laws on cardiovascular health outcomes). These inclusion criteria were informed by
Bogenschneider’s definition of policy [6] and domains of
health policy research proposed by Brownson and colleagues [3–5]. For projects classified as policy D&I, we

searched for its NIH project number in ClinicalTrials.gov [39] and PubMed [40] to obtain additional information and validate coding decisions.
We calculated the total dollar amount awarded
through all NIH research grants and through the D&I
FOAs, stratified by funding mechanism and Institute.
We also calculated the amount awarded for policy D&I
projects, and the percentage of total D&I FOA funding
they comprised, within strata. Data were managed and
analyzed in Microsoft Excel.

Results and discussion
Between 2007 and 2014, 146 projects were funded
through the D&I FOAs, 12 (8.2 %) of which were classified
as policy D&I research (Fig. 1). A total of $16,177,250 was
awarded for these projects, equivalent to 10.5 % of all
funding through the D&I FOAs (Table 1). The NIH Office
of the Director allocated 69.7 % of its D&I FOA funding
to a policy D&I project, indicating agency-level support
for the field. The National Cancer Institute (NCI) was the
primary funder of policy D&I research, supporting six projects which comprised 13.0 % of all NCI funding through
the D&I FOAs. Some Institutes that were engaged in D&I
funding—such as the National Institute of Nursing Research which funded seven D&I projects comprising over
1.0 % of the Institute’s total research grant spending, a
proportion larger than any other Institute—did not fund
any policy D&I projects. Differences in policy D&I funding
between Institutes could potentially be a reflection of
varying levels of knowledge about policy D&I research
among investigators within different health science disciplines or differences in the degree to which the disciplines
are clinically, as opposed to policy, oriented.

Purtle et al. Implementation Science (2016) 11:1
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Table 2 NIH-funded policy D&I research projects by study
characteristics, federal fiscal years 2007–2014

Table 2 NIH-funded policy D&I research projects by study
characteristics, federal fiscal years 2007–2014 (Continued)

Study characteristics

Policy documents

Number of policy
D&I projects (%)a
(N = 12)

Domain of policy research
Outcome

8 (66.7 %)

Process

5 (41.7 %)

Content

1 (8.3 %)

Type of policy
Public (e.g., laws, regulations)

6 (50.0 %)

Heath care financing/reimbursement

3 (25.0 %)

Workplace

2 (16.7 %)

Clinical practice

1 (8.3 %)

Level of policy
State

5 (41.7 %)

Local

3 (25.0 %)

Organization

3 (25.0 %)

National

1 (8.3 %)

Region of research focus
USA

10 (83.3 %)

Outside of USA

2 (16.7 %)

Health issue
Tobacco

4 (33.3 %)

Cancer

3 (25.0 %)

Drug abuse

2 (16.7 %)

Mental health

2 (16.7 %)

Child welfare

2 (16.7 %)

Implementation science objectives
Implementation

5 (41.7 %)

Dissemination

4 (33.3 %)

Adoption

2 (16.7 %)

Sustainability

1 (8.3 %)

Study design

3 (25.0 %)

Healthcare providers

3 (25.0 %)

Administrative documents

3 (25.0 %)

Medical records

3 (25.0 %)

Community stakeholders

2 (16.7 %)

Media coverage

1 (8.3 %)

Unknown

1 (8.3 %)

NIH National Institutes of Health, D&I dissemination and implementation
a
Some percentages exceed 100 because categories were not mutually exclusive

NIH funding for policy D&I increased between 2007
and 2014 (Fig. 2). Annual policy D&I funding increased
by 98.9 % within this period, from $1,584,327 in 2007 to
$3,151,286 in 2014. The proportion of funding awarded
through the D&I FOAs that was for policy D&I projects
ranged from 14.6 % in 2007 to 8.0 % in 2011. Between
2012 and 2013, funding decreased by 6.3 % for all NIH
research grants and increased by 7.4 % for projects
funded through the D&I FOAs and by 51.8 % for policy
D&I projects.
NIH-funded policy D&I projects utilized a range of
methodologies and data sources across different domains
of policy research (Tables 2, 3, Additional file 1). These
projects were primarily focused on policy outcomes
(66.7 %), implementation research (41.7 %), state-level policies (41.7 %), and the USA (83.3 %). Tobacco (33.3 %)
and cancer control (25.0 %), for which evidence-based policy strategies exist [41, 42], were the most common topics
of focus. Many projects combined survey (58.3 %) and
interview (33.3 %) methods with analysis of archival data
sources, such as medical records (25.0 %) and policy documents (25.0 %). It was unclear; however, the extent to
which projects used true mixed-method designs (e.g., the
results of one method informed data collection of the
other, or the results of both methods were presented
together).

Quasi-experimental

5 (41.7 %)

Non-experimental

4 (33.3 %)

Limitations

Experimental

3 (25.0 %)

We limited our review to projects funded through FOAs
explicitly focused on D&I and may not have identified all
NIH-funded policy D&I projects. Our review also did not
capture policy D&I projects funded by other US government agencies or philanthropies. We did not attempt to obtain the full text of proposals and thus did not have
complete information on project characteristics, such as information on how the projects planned to disseminate their
findings. We also did not have data on the characteristics of
policy D&I research proposals that were unsuccessful in
obtaining funding through NIH. Thus, we were unable to
identify specific characteristics that increased the likelihood
of a policy D&I project being funded. We dichotomously

Methods used
Quantitative, surveys

7 (58.3 %)

Qualitative, interviews

4 (33.3 %)

Quantitative, medical record review

3 (25.0 %)

Content analysis, document analysis

3 (25.0 %)

Qualitative, focus groups

1 (8.3 %)

Quantitative, agent-based modeling

1 (8.3 %)

Content analysis, media analysis

1 (8.3 %)

Data source
Policymakers

3 (25.0 %)

Purtle et al. Implementation Science (2016) 11:1

categorized projects as policy D&I (yes/no) and did not differentiate between projects in which policy D&I was the
primary focus or subcomponent. Because only 12 policy
D&I projects were identified, subgroup differences and
comparisons should be interpreted with caution.

Conclusions
NIH has made an initial investment in policy D&I research,
signaling that the field might be entering the mainstream
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US health research enterprise. The level of support for policy D&I research, however, has varied between Institutes
and is probably not commensurate with the potential of
evidence-based policy to positively impact human health.
Policy D&I researchers have utilized a variety of designs,
methods, and data sources to investigate the development
processes, content, and outcomes of public and private
policies. By mapping the characteristics of NIH funded
policy D&I research projects, the current study provides

Table 3 NIH-funded policy D&I research projects by individual project details, federal fiscal years 2007–2014 (N = 12)
Project
number

Title

Objective

Funding
source

Start date

Country
of focus

R01HL086450

An intervention for
promoting smoke-free policy
in rural Kentucky

To test the effects of a community intervention on
smoke-free policy outcomes in rural underserved
communities

NHLBI

April 1, 2007

US

R01CA124404

Cancer control dissemination
research among state-level
policy makers

To increase the dissemination of evidence-based
interventions to control cancer, primarily focusing
on the uptake of effective environmental and policy
approaches among state-level policy makers

NCI

September 27, 2007 US

R01MH072961 Mixed methods study of EBP
sustainment in a statewide
service system
R01CA160327

To examine factors that either support or limit sustainment NIMH
of an evidence-based child neglect intervention in a large
statewide public service system

Disseminating evidenceTo increase the dissemination of EBPPs to control cancer,
based interventions to control focusing on the uptake of effective approaches among
cancer
state-level practitioners

September 22, 2005 US

NCI/OD

May 3, 2012

US

R01DA030431 To test a payer/treatment
agency intervention to
increase use of
buprenorphine

To test whether clinician training and the use of
organizational change strategies are sufficient for
disseminating an evidence-based practice (EBP),
or if changes to both organizational systems and
payer policy result in greater EBP use

NIDA

March 1, 2012

US

R03CA128644

Translating science into
policy: a survey of state
tobacco control plans

To examine the structures and processes used by
states to develop strategic plans to reduce tobacco
use and prevent initiation

NCI

June 2, 2008

US

R21CA136435

Workplace health promotion

To enhance the dissemination potential of a
successful intervention, Workplace Solutions
that was developed to disseminate a set of
15 evidence - based cancer prevention strategies
to workplaces

NCI

July 16, 2009

US

R01MH104200 Value-based purchasing in
implementation of
depression care in
community clinics

To assess the role of value-based purchasing (VBP),
a policy strategy, to enhance planned implementation
of evidence-based care in CHCs

NIMH

August 1, 2014

US

R01CA175329

To fill the current research-to-practice gap by conducting a
randomized controlled trial that compares the
effectiveness and cost effectiveness of two practical
and highly replicable strategies for implementing
evidence-based guidelines for the treatment of
tobacco use in public health clinics in Vietnam

NCI

September 30, 2013 Vietnam

R21MH098124 Development and validation
of implementation climate
measures

To develop measures of organizational climate, leadership,
and provider behaviors likely to impact the
implementation of evidence-based practices

NIMH

June 24, 2013

US

R21CA172938

A retail policy laboratory:
modeling impact of retailer
reduction on tobacco use

To examine the interplay between retailer density
reductions and patterns of tobacco purchasing

NCI

July 1, 2013

US

R21AI095979

Sustainable financial
incentives to improve
prescription practices for
malaria

To test an innovative, sustainable financial incentive
NIAID
designed to reduce the number of non-malarial fevers that
are treated inappropriately with antimalarial drugs

April 1, 2012

Kenya

Implementing tobacco use
treatment guidelines in
community health centers in
Vietnam

US United States, NIH National Institutes of Health, NCI National Cancer Institute, NIMH National Institute of Mental Health, NIDA National Institute on Drug Abuse,
NHLBI National Heart, Lung, and Blood Institute, OD NIH Office of the Director, NIAID National Institute of Allergy and Infectious Diseases, D&I dissemination and implementation
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investigators with guidance on approaches to policy D&I
research that they can consider when conceptualizing
research ideas and developing NIH proposals in this area.
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Additional file 1: NIH-funded policy D&I projects. (XLSM 583 kb)
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JP conceptualized and designed the study. JP and RP developed the search
strategy, reviewed, and coded projects. RB provided guidance and direction
throughout the research process. JP drafted the manuscript and was responsible
for overseeing revisions. RP and RB provided reviews of the manuscript and
suggested edits that were addressed. All authors approved the final version of
the manuscript.
Author details
1
Department of Health Management & Policy, Drexel University School of
Public Health, 3215 Market St., Philadelphia, PA 19104, USA. 2Brown School,
Division of Public Health Sciences, and Siteman Cancer Center, Washington
University in St. Louis and Washington University School of Medicine, One
Brookings Drive, Campus Box 1196, St. Louis, MO 63130, USA.
Received: 26 August 2015 Accepted: 30 December 2015

References
1. Institute of Medicine. For the public’s health: revitalizing law and policy to
meet new challenges. Washington, DC: The National Academies Press; 2011.
2. Burris S, Wagenaar AC, Swanson J, Ibrahim JK, Wood J, Mello MM. Making
the case for laws that improve health: a framework for public health law
research. Milbank Q. 2010;88(2):169–210.
3. Brownson RC, Chriqui JF, Stamatakis KA. Understanding evidence-based
public health policy. Am J Public Health. 2009;99(9):1576–83.
4. Brownson RC, Seiler R, Eyler AA. Measuring the impact of public health
policy. Prev Chronic Dis. 2010;7(4):A77.
5. Dodson E, Brownson RC, Weiss S. Policy dissemination research. In:
Brownson RC, Colditz GA, Proctor EK, editors. Dissemination and
implementation research in health: translating science to practice. New
York, NY: Oxford University Press; 2012. p. 437–58.
6. Bogenschneider K, Corbett TJ. Evidence-based policymaking: insights from
policy-minded researchers and research-minded policymakers. New York,
NY: Routledge; 2011.
7. Weiss CH. The many meanings of research utilization. Pub Admin Rev. 1979;
39(5):426–31.
8. Innvær S, Vist G, Trommald M, Oxman A. Health policy-makers’ perceptions
of their use of evidence: a systematic review. J Health Serv Res Policy. 2002;
7(4):239–44.
9. Brownson RC, Royer C, Ewing R, McBride TD. Researchers and policymakers:
travelers in parallel universes. Am J Prev Med. 2006;30(2):164–72.
10. De Leeuw E, Clavier C, Breton E. Health policy—why research it and how:
health political science. Health Res Policy Syst. 2014;12(1):55.
11. Orton L, Lloyd-Williams F, Taylor-Robinson D, O’Flaherty M, Capewell S. The
use of research evidence in public health decision making processes:
systematic review. PLoS One. 2011;6(7):e21704.
12. Oliver K, Innvar S, Lorenc T, Woodman J, Thomas J. A systematic review of
barriers to and facilitators of the use of evidence by policymakers. BMC
Health Serv Res. 2014;14(1):2.
13. Hanney SR, Gonzalez-Block MA, Buxton MJ, Kogan M. The utilisation of
health research in policy-making: concepts, examples and methods of
assessment. Health Res Policy Syst. 2003;1(1):2.
14. Liverani M, Hawkins B, Parkhurst JO. Political and institutional influences on
the use of evidence in public health policy. A systematic review. PLoS One.
2013;8(10):e77404.
15. Oliver TR. The politics of public health policy. Annu Rev Public Health. 2006;
27(1):195–233.

Page 7 of 8

16. Jewell CJ, Bero LA. “Developing good taste in evidence”: facilitators of and
hindrances to evidence‐informed health policymaking in state government.
Milbank Q. 2008;86(2):177–208.
17. Caplan N. The two-communities theory and knowledge utilization. Am
Behav Sci. 1979;22(3):459.
18. Ellen ME, Lavis JN, Sharon A, Shemer J. Health systems and policy
research evidence in health policy making in Israel: what are
researchers’ practices in transferring knowledge to policy makers?
Health Res Policy Syst. 2014;12(1):67.
19. Lindblom CE, Cohen DK. Usable knowledge: social science and social
problem solving, vol. 21. New Haven, CT: Yale University Press; 1979.
20. Lomas J. Diffusion, dissemination, and implementation: who should do
what? Ann N Y Acad Sci. 1993;703(1):226–37.
21. Lester JP, Wilds LJ. The utilization of public policy analysis: a conceptual
framework. Eval Program Plann. 1990;13(3):313–9.
22. Lavis JN, Lomas J, Hamid M, Sewankambo NK. Assessing country-level
efforts to link research to action. Bull World Health Organ. 2006;84(8):
620–8.
23. Boyko JA, Lavis JN, Dobbins M, Souza NM. Reliability of a tool for measuring
theory of planned behaviour constructs for use in evaluating research use
in policymaking. Health Res Policy Syst. 2011;9(1):29.
24. Dobbins M, Ciliska D, Cockerill R, Barnsley J, DiCenso A. A framework for the
dissemination and utilization of research for health‐care policy and practice.
Worldviews Evid Based Nurs. 2002;E9(1):149–60.
25. Glasgow RE, Green LW, Taylor MV, Stange KC. An evidence integration
triangle for aligning science with policy and practice. Am J Prev Med. 2012;
42(6):646–54.
26. Samet JM. Epidemiology and policy: the pump handle meets the new
millennium. Epidemiol Rev. 2000;22(1):145–54.
27. Petticrew M, Whitehead M, Macintyre SJ, Graham H, Egan M. Evidence for
public health policy on inequalities: 1: the reality according to policymakers.
J Epidemiol Community Health. 2004;58(10):811–6.
28. Panisset U, Campbell S, Lavis J. 2012–2015 Strategic plan: towards a world
in which the best available research evidence informs health policy-making.
World Health Organization. 2012. http://www.who.int/evidence/
OMSEVIPNetStratPlan.pdf?ua=1. Accessed 1 Dec 2015.
29. World Health Organization. World report on knowledge for better
health: strengthening health systems. 2004. http://www.who.int/rpc/
meetings/en/world_report_on_knowledge_for_better_health2.pdf.
Accessed 1 Dec 2015.
30. Sibbald SL, Tetroe J, Graham ID. Research funder required research
partnerships: a qualitative inquiry. Implement Sci. 2014;9(1):176.
31. Glasgow RE, Vinson C, Chambers D, Khoury MJ, Kaplan RM, Hunter C.
National Institutes of Health approaches to dissemination and
implementation science: current and future directions. Am J of Public
Health. 2012;102(7):1274–81.
32. National Institutes of Health. Dissemination and implementation research in
mental health. 2002. http://grants.nih.gov/grants/guide/pa-files/PA-02-131.
html. Accessed 1 Dec 2015.
33. National Institutes of Health. Dissemination and implementation research in
mental health. 2005. https://grants.nih.gov/grants/guide/pa-files/PAR-06-039.
html. Accessed 1 Dec 2015.
34. Glasgow RE, Chambers DA, Cynkin L. News from the NIH: highlights in
implementation science from the National Cancer Institute and the National
Institute of Mental Health. Transl Behav Med. 2013;3(4):335–7.
35. National Institutes of Health. Dissemination and implementation research in
health (R01). 2013. http://grants.nih.gov/grants/guide/pa-files/PAR-13-055.
html. Accessed 20 Aug 2015.
36. Tinkle M, Kimball R, Haozous EA, Shuster G, Meize-Grochowski R.
Dissemination and implementation research funded by the US National
Institutes of Health, 2005–2012. Nurs Res Pract. 2013;2013:1–15.
37. Neta G, Sanchez MA, Chambers DA, Phillips SM, Leyva B, Cynkin L, et al.
Implementation science in cancer prevention and control: a decade of
grant funding by the National Cancer Institute and future directions.
Implement Sci. 2015;10(1):4.
38. Research Portfolio Online Reporting Tools (RePORT). http://report.nih.gov/.
Accessed 20 Aug 2015.
39. ClinicalTrials.gov. https://clinicaltrials.gov/. Accessed 20 Aug 2015.
40. PubMed. http://www.ncbi.nlm.nih.gov/pubmed. Accessed 20 Aug 2015.
41. Community Preventive Services Taskforce. Guide to community preventive
services. Preventing skin cancer: education and policy approaches. http://

Purtle et al. Implementation Science (2016) 11:1

Page 8 of 8

www.thecommunityguide.org/cancer/skin/education-policy/index.html.
Accessed 20 Aug 2015.
42. Community Preventive Services Taskforce. Guide to community preventive
services. Reducing tobacco use and secondhand smoke exposure: smokefree policies. http://www.thecommunityguide.org/tobacco/
smokefreepolicies.html. Accessed 20 Aug 2015.

Submit your next manuscript to BioMed Central
and we will help you at every step:
• We accept pre-submission inquiries
• Our selector tool helps you to find the most relevant journal
• We provide round the clock customer support
• Convenient online submission
• Thorough peer review
• Inclusion in PubMed and all major indexing services
• Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit

